Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 130.42%4.57K | 16.06%-93.4K | -16.76%-41.02K | 98.66%-221 | -69.40%-37.15K | 60.26%-15.01K | 74.16%-111.27K | 25.75%-35.13K | 85.59%-16.43K | 77.11%-21.93K |
| Net income from continuing operations | 21.18%-168.5K | 17.36%-1.23M | -23.91%-502.83K | -31.98%-428.9K | 71.70%-87.18K | 52.80%-213.77K | 31.26%-1.49M | 50.70%-405.8K | 1.04%-324.98K | 44.25%-308.04K |
| Operating gains losses | ---- | -81.40%-163.33K | -66.75%-100.58K | --0 | ---- | ---- | 74.03%-90.04K | 81.67%-60.32K | --0 | ---- |
| Depreciation and amortization | ---- | --0 | --0 | --0 | --0 | --0 | -99.14%696 | -98.55%294 | -99.33%135 | -99.35%132 |
| Asset impairment expenditure | ---- | -36.56%5.82K | ---- | ---- | ---- | ---- | -95.28%9.17K | ---- | ---- | ---- |
| Remuneration paid in stock | ---- | --0 | --0 | --0 | --0 | --0 | 276.08%250.34K | --0 | --75K | --0 |
| Other non cashItems | 16.33%12.01K | -361.84%-104.44K | -1,369.10%-138.76K | 5.90%11.06K | -26.06%12.95K | 934.07%10.32K | -92.56%39.89K | -97.85%10.93K | 7.14%10.45K | 99.65%17.51K |
| Change In working capital | -14.53%161.06K | 19.72%1.4M | 69.35%695.34K | 87.30%417.62K | -66.52%99.84K | -21.04%188.44K | -3.15%1.17M | 23.70%410.59K | 20.91%222.96K | -32.68%298.19K |
| -Change in receivables | -258.58%-4.29K | -98.02%-11.69K | -342.52%-19.78K | -33.54%-2.35K | 883.01%11.63K | -38.95%-1.2K | -140.54%-5.9K | -205.25%-4.47K | -104.81%-1.76K | 129.68%1.18K |
| -Change in prepaid assets | --0 | -98.31%1.59K | --0 | --227 | --682 | -99.29%682 | -33.09%94.11K | 97.81%-1.57K | --0 | --0 |
| -Change in payables and accrued expense | -12.64%165.07K | 29.59%1.41M | 71.07%715.11K | 85.27%419.74K | -70.71%87.53K | 29.71%188.95K | 2.69%1.09M | 4.17%418.02K | 49.16%226.56K | -17.23%298.85K |
| -Change in other working capital | --278 | ---- | ---- | ---- | ---- | ---- | 5.98%-6.92K | 29.11%-1.4K | -7.92%-1.84K | 0.00%-1.84K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 130.42%4.57K | 16.06%-93.4K | -16.76%-41.02K | 98.66%-221 | -69.40%-37.15K | 60.26%-15.01K | 74.16%-111.27K | 25.75%-35.13K | 85.59%-16.43K | 77.11%-21.93K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 67.21%-819 | 194.95%1.5K | -2.05K | ||||
| Net intangibles purchas and sale | ---- | --0 | --0 | --0 | ---- | ---- | 67.21%-819 | 194.95%1.5K | ---2.05K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | --0 | --0 | --0 | ---- | ---- | 67.21%-819 | 194.95%1.5K | ---2.05K | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -0.50%79.8K | -25.40%29K | -97.39%800 | 279.45%50K | 0 | -81.54%80.2K | -30.84%38.88K | -56.41%30.65K | -92.31%13.18K | |
| Net issuance payments of debt | ---- | -91.44%800 | --0 | 23.84%800 | --0 | --0 | -91.81%9.34K | -78.62%12.02K | -96.82%646 | ---823 |
| Net common stock issuance | ---- | 88.74%79K | ---- | ---- | ---- | ---- | -86.93%41.86K | -83.28%45.21K | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | --29K | ---15K | --30K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | -0.50%79.8K | -25.40%29K | -97.39%800 | 279.45%50K | --0 | -81.54%80.2K | -30.84%38.88K | -56.41%30.65K | -92.31%13.18K |
| Net cash flow | ||||||||||
| Beginning cash position | -86.15%1.84K | -72.92%13.25K | -85.02%1.48K | -27.86%712 | -87.84%800 | -72.92%13.25K | 2.58%48.93K | -76.29%9.88K | -98.84%987 | -39.38%6.58K |
| Current changes in cash | 130.42%4.57K | 57.36%-13.6K | -328.93%-12.02K | -95.24%579 | 242.50%12.86K | 62.73%-15.01K | -2,560.57%-31.89K | -28.19%5.25K | 127.81%12.16K | -112.10%-9.02K |
| Cash adjustments other than cash changes | -299.45%-5.11K | 157.55%2.18K | 758.19%12.37K | 105.79%189 | -477.46%-12.94K | 223.67%2.56K | -5,818.75%-3.79K | -2,837.50%-1.88K | ---3.27K | --3.43K |
| End cash Position | 62.00%1.3K | -86.15%1.84K | -86.15%1.84K | -85.02%1.48K | -27.86%712 | -87.84%800 | -72.92%13.25K | -72.92%13.25K | -76.29%9.88K | -98.84%987 |
| Free cash from | 130.42%4.57K | 16.68%-93.4K | -21.99%-41.02K | 98.80%-221 | -67.33%-37.15K | 60.26%-15.01K | 74.12%-112.09K | 31.11%-33.63K | 83.79%-18.48K | 77.07%-22.2K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.